The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

Market Overview

• Current Size: The cardiovascular health supplements market will grow from $11.67 billion in 2023 to $13.11 billion in 2024, with a CAGR of 12.3%.
• Future Projections: Expected to reach $20.98 billion by 2028, growing at a CAGR of 12.5%.

Historical Growth Drivers

• Less Invasive Techniques: Shift towards less invasive surgical methods and increased demand for structural heart devices.
• Healthcare Training: Ongoing training and education programs for healthcare professionals.
• Healthcare Expenditure: Rising investments in healthcare and increased awareness of heart health.

Future Growth Drivers

• Aging Population: Growing number of elderly individuals requiring cardiovascular support.
• Awareness and Screening: Increased awareness about heart health and implementation of screening programs.
• Reimbursement Policies: Favorable policies for structural heart procedures and timely regulatory approvals.

View More On The Cardiovascular Health Supplements Market Report 2024 –
https://www.thebusinessresearchcompany.com/report/cardiovascular-health-supplements-global-market-report

Rising Prevalence of Heart-Related Diseases

• Cardiovascular Diseases (CVD): Conditions like heart failure, coronary heart disease, and related illnesses are on the rise due to factors like inactivity, poor diet, smoking, and stress.
• Statistics: The British Heart Foundation reported 17,639 deaths from heart and circulatory diseases in Scotland in 2021, up from 17,448 in 2020.

Major Market Players

• Key Companies: Pfizer, Johnson & Johnson, Amway, Herbalife Nutrition, General Nutrition Centers (GNC), NOW Health Group, and others.
• Focus Areas: Companies are developing new products and natural ingredients to address cardiovascular health needs.

Innovations and New Product Developments

• Advanced Plant Sterols: Introduction of natural plant products like dispersible phytosterols aimed at lowering cholesterol levels.
  • Example: Nutrartis launched Cardiosmile in September 2023, a liquid supplement containing water-dispersible phytosterols for cholesterol management.

Strategic Acquisitions

• Sanofi and Qunol: In September 2023, Sanofi acquired Qunol to enhance its position in the vitamin and supplement market, focusing on cardiovascular health supplements for the aging population.

Market Segmentation

• By Type: Natural Supplements, Synthetic Supplements.
• By Ingredient: Vitamins and Minerals, Herbs and Botanicals, Omega Fatty Acids, Coenzyme Q10 (CoQ10), Other Ingredients.
• By Form: Liquid, Tablet, Capsules, Softgels, Powder, Other Forms.
• By Distribution Channel: Offline, Online.

Regional Insights

• Asia-Pacific: The largest market in 2023, with continued dominance expected in the forecast period.

The cardiovascular health supplements market is expanding rapidly, driven by increasing heart disease prevalence, advancements in supplement formulations, and strategic market moves by major players. The emphasis on natural ingredients and innovations in product development will likely sustain growth in this sector.

Request A Sample Of The Global Cardiovascular Health Supplements Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15533&type=smp